Global Artificial Cardiopulmonary Machine Market Research Report 2023

Publisher Name :
Date: 17-Nov-2023
No. of pages: 86
Inquire Before Buying

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Artificial Cardiopulmonary Machine market with multiple angles, which provides sufficient supports to readers' strategy and decision making.

By Company

- LivaNova (Sorin)

- Getinge (Maquet)

- Medtronic

- Terumo CV Group

- Braile Biomedica

- Tianjin Medical

Segment by Type

- Single Roller Pump HLM

- Double Roller Pump HLM

Segment by Application

- Cardiac Surgery

- Lung Transplant Operation

- Acute Respiratory Failure Treatment

- Others

Consumption by Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

The Artificial Cardiopulmonary Machine report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Manufacturers' Competition Patterns

Chapter 3: Country Level Sales Analysis

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6: Manufacturers' Outline

Chapter 7: Industry Chain, Market Channel and Customer Analysis

Chapter 8: Market Opportunities and Challenges

Chapter 9: Market Conclusions

Chapter 10: Research Methodology and Data Source

Global Artificial Cardiopulmonary Machine Market Research Report 2023

Table of Contents
1 Artificial Cardiopulmonary Machine Market Overview
1.1 Product Overview and Scope of Artificial Cardiopulmonary Machine
1.2 Artificial Cardiopulmonary Machine Segment by Type
1.2.1 Global Artificial Cardiopulmonary Machine Market Value Comparison by Type (2023-2029)
1.2.2 Single Roller Pump HLM
1.2.3 Double Roller Pump HLM
1.3 Artificial Cardiopulmonary Machine Segment by Application
1.3.1 Global Artificial Cardiopulmonary Machine Market Value by Application: (2023-2029)
1.3.2 Cardiac Surgery
1.3.3 Lung Transplant Operation
1.3.4 Acute Respiratory Failure Treatment
1.3.5 Others
1.4 Global Artificial Cardiopulmonary Machine Market Size Estimates and Forecasts
1.4.1 Global Artificial Cardiopulmonary Machine Revenue 2018-2029
1.4.2 Global Artificial Cardiopulmonary Machine Sales 2018-2029
1.4.3 Global Artificial Cardiopulmonary Machine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Artificial Cardiopulmonary Machine Market Competition by Manufacturers
2.1 Global Artificial Cardiopulmonary Machine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Artificial Cardiopulmonary Machine Average Price by Manufacturers (2018-2023)
2.4 Global Artificial Cardiopulmonary Machine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Artificial Cardiopulmonary Machine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Cardiopulmonary Machine, Product Type & Application
2.7 Artificial Cardiopulmonary Machine Market Competitive Situation and Trends
2.7.1 Artificial Cardiopulmonary Machine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artificial Cardiopulmonary Machine Players Market Share by Revenue
2.7.3 Global Artificial Cardiopulmonary Machine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Cardiopulmonary Machine Retrospective Market Scenario by Region
3.1 Global Artificial Cardiopulmonary Machine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Artificial Cardiopulmonary Machine Global Artificial Cardiopulmonary Machine Sales by Region: 2018-2029
3.2.1 Global Artificial Cardiopulmonary Machine Sales by Region: 2018-2023
3.2.2 Global Artificial Cardiopulmonary Machine Sales by Region: 2024-2029
3.3 Global Artificial Cardiopulmonary Machine Global Artificial Cardiopulmonary Machine Revenue by Region: 2018-2029
3.3.1 Global Artificial Cardiopulmonary Machine Revenue by Region: 2018-2023
3.3.2 Global Artificial Cardiopulmonary Machine Revenue by Region: 2024-2029
3.4 North America Artificial Cardiopulmonary Machine Market Facts & Figures by Country
3.4.1 North America Artificial Cardiopulmonary Machine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Artificial Cardiopulmonary Machine Sales by Country (2018-2029)
3.4.3 North America Artificial Cardiopulmonary Machine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Artificial Cardiopulmonary Machine Market Facts & Figures by Country
3.5.1 Europe Artificial Cardiopulmonary Machine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Artificial Cardiopulmonary Machine Sales by Country (2018-2029)
3.5.3 Europe Artificial Cardiopulmonary Machine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Cardiopulmonary Machine Market Facts & Figures by Country
3.6.1 Asia Pacific Artificial Cardiopulmonary Machine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Artificial Cardiopulmonary Machine Sales by Country (2018-2029)
3.6.3 Asia Pacific Artificial Cardiopulmonary Machine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Artificial Cardiopulmonary Machine Market Facts & Figures by Country
3.7.1 Latin America Artificial Cardiopulmonary Machine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Artificial Cardiopulmonary Machine Sales by Country (2018-2029)
3.7.3 Latin America Artificial Cardiopulmonary Machine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Cardiopulmonary Machine Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Cardiopulmonary Machine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Artificial Cardiopulmonary Machine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artificial Cardiopulmonary Machine Sales by Type (2018-2029)
4.1.1 Global Artificial Cardiopulmonary Machine Sales by Type (2018-2023)
4.1.2 Global Artificial Cardiopulmonary Machine Sales by Type (2024-2029)
4.1.3 Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2029)
4.2 Global Artificial Cardiopulmonary Machine Revenue by Type (2018-2029)
4.2.1 Global Artificial Cardiopulmonary Machine Revenue by Type (2018-2023)
4.2.2 Global Artificial Cardiopulmonary Machine Revenue by Type (2024-2029)
4.2.3 Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2018-2029)
4.3 Global Artificial Cardiopulmonary Machine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Artificial Cardiopulmonary Machine Sales by Application (2018-2029)
5.1.1 Global Artificial Cardiopulmonary Machine Sales by Application (2018-2023)
5.1.2 Global Artificial Cardiopulmonary Machine Sales by Application (2024-2029)
5.1.3 Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2018-2029)
5.2 Global Artificial Cardiopulmonary Machine Revenue by Application (2018-2029)
5.2.1 Global Artificial Cardiopulmonary Machine Revenue by Application (2018-2023)
5.2.2 Global Artificial Cardiopulmonary Machine Revenue by Application (2024-2029)
5.2.3 Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2018-2029)
5.3 Global Artificial Cardiopulmonary Machine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 LivaNova (Sorin)
6.1.1 LivaNova (Sorin) Corporation Information
6.1.2 LivaNova (Sorin) Description and Business Overview
6.1.3 LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 LivaNova (Sorin) Artificial Cardiopulmonary Machine Product Portfolio
6.1.5 LivaNova (Sorin) Recent Developments/Updates
6.2 Getinge (Maquet)
6.2.1 Getinge (Maquet) Corporation Information
6.2.2 Getinge (Maquet) Description and Business Overview
6.2.3 Getinge (Maquet) Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Getinge (Maquet) Artificial Cardiopulmonary Machine Product Portfolio
6.2.5 Getinge (Maquet) Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medtronic Artificial Cardiopulmonary Machine Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Terumo CV Group
6.4.1 Terumo CV Group Corporation Information
6.4.2 Terumo CV Group Description and Business Overview
6.4.3 Terumo CV Group Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Terumo CV Group Artificial Cardiopulmonary Machine Product Portfolio
6.4.5 Terumo CV Group Recent Developments/Updates
6.5 Braile Biomedica
6.5.1 Braile Biomedica Corporation Information
6.5.2 Braile Biomedica Description and Business Overview
6.5.3 Braile Biomedica Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Braile Biomedica Artificial Cardiopulmonary Machine Product Portfolio
6.5.5 Braile Biomedica Recent Developments/Updates
6.6 Tianjin Medical
6.6.1 Tianjin Medical Corporation Information
6.6.2 Tianjin Medical Description and Business Overview
6.6.3 Tianjin Medical Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Tianjin Medical Artificial Cardiopulmonary Machine Product Portfolio
6.6.5 Tianjin Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Cardiopulmonary Machine Industry Chain Analysis
7.2 Artificial Cardiopulmonary Machine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Cardiopulmonary Machine Production Mode & Process
7.4 Artificial Cardiopulmonary Machine Sales and Marketing
7.4.1 Artificial Cardiopulmonary Machine Sales Channels
7.4.2 Artificial Cardiopulmonary Machine Distributors
7.5 Artificial Cardiopulmonary Machine Customers
8 Artificial Cardiopulmonary Machine Market Dynamics
8.1 Artificial Cardiopulmonary Machine Industry Trends
8.2 Artificial Cardiopulmonary Machine Market Drivers
8.3 Artificial Cardiopulmonary Machine Market Challenges
8.4 Artificial Cardiopulmonary Machine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Artificial Cardiopulmonary Machine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Artificial Cardiopulmonary Machine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Artificial Cardiopulmonary Machine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Artificial Cardiopulmonary Machine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Artificial Cardiopulmonary Machine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Artificial Cardiopulmonary Machine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Artificial Cardiopulmonary Machine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Artificial Cardiopulmonary Machine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Artificial Cardiopulmonary Machine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Artificial Cardiopulmonary Machine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Artificial Cardiopulmonary Machine, Product Type & Application
Table 12. Global Key Manufacturers of Artificial Cardiopulmonary Machine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Artificial Cardiopulmonary Machine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Cardiopulmonary Machine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Artificial Cardiopulmonary Machine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Artificial Cardiopulmonary Machine Sales by Region (2018-2023) & (K Units)
Table 18. Global Artificial Cardiopulmonary Machine Sales Market Share by Region (2018-2023)
Table 19. Global Artificial Cardiopulmonary Machine Sales by Region (2024-2029) & (K Units)
Table 20. Global Artificial Cardiopulmonary Machine Sales Market Share by Region (2024-2029)
Table 21. Global Artificial Cardiopulmonary Machine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Artificial Cardiopulmonary Machine Revenue Market Share by Region (2018-2023)
Table 23. Global Artificial Cardiopulmonary Machine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Artificial Cardiopulmonary Machine Revenue Market Share by Region (2024-2029)
Table 25. North America Artificial Cardiopulmonary Machine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Artificial Cardiopulmonary Machine Sales by Country (2018-2023) & (K Units)
Table 27. North America Artificial Cardiopulmonary Machine Sales by Country (2024-2029) & (K Units)
Table 28. North America Artificial Cardiopulmonary Machine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Artificial Cardiopulmonary Machine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Artificial Cardiopulmonary Machine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Artificial Cardiopulmonary Machine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Artificial Cardiopulmonary Machine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Artificial Cardiopulmonary Machine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Artificial Cardiopulmonary Machine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Artificial Cardiopulmonary Machine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Artificial Cardiopulmonary Machine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Artificial Cardiopulmonary Machine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Artificial Cardiopulmonary Machine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Artificial Cardiopulmonary Machine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Artificial Cardiopulmonary Machine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Artificial Cardiopulmonary Machine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Artificial Cardiopulmonary Machine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Artificial Cardiopulmonary Machine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Artificial Cardiopulmonary Machine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Artificial Cardiopulmonary Machine Sales (K Units) by Type (2018-2023)
Table 51. Global Artificial Cardiopulmonary Machine Sales (K Units) by Type (2024-2029)
Table 52. Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
Table 53. Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2024-2029)
Table 54. Global Artificial Cardiopulmonary Machine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Artificial Cardiopulmonary Machine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2018-2023)
Table 57. Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2024-2029)
Table 58. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Artificial Cardiopulmonary Machine Sales (K Units) by Application (2018-2023)
Table 61. Global Artificial Cardiopulmonary Machine Sales (K Units) by Application (2024-2029)
Table 62. Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2018-2023)
Table 63. Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2024-2029)
Table 64. Global Artificial Cardiopulmonary Machine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Artificial Cardiopulmonary Machine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2018-2023)
Table 67. Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2024-2029)
Table 68. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Application (2024-2029)
Table 70. LivaNova (Sorin) Corporation Information
Table 71. LivaNova (Sorin) Description and Business Overview
Table 72. LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. LivaNova (Sorin) Artificial Cardiopulmonary Machine Product
Table 74. LivaNova (Sorin) Recent Developments/Updates
Table 75. Getinge (Maquet) Corporation Information
Table 76. Getinge (Maquet) Description and Business Overview
Table 77. Getinge (Maquet) Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Getinge (Maquet) Artificial Cardiopulmonary Machine Product
Table 79. Getinge (Maquet) Recent Developments/Updates
Table 80. Medtronic Corporation Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Medtronic Artificial Cardiopulmonary Machine Product
Table 84. Medtronic Recent Developments/Updates
Table 85. Terumo CV Group Corporation Information
Table 86. Terumo CV Group Description and Business Overview
Table 87. Terumo CV Group Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Terumo CV Group Artificial Cardiopulmonary Machine Product
Table 89. Terumo CV Group Recent Developments/Updates
Table 90. Braile Biomedica Corporation Information
Table 91. Braile Biomedica Description and Business Overview
Table 92. Braile Biomedica Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Braile Biomedica Artificial Cardiopulmonary Machine Product
Table 94. Braile Biomedica Recent Developments/Updates
Table 95. Tianjin Medical Corporation Information
Table 96. Tianjin Medical Description and Business Overview
Table 97. Tianjin Medical Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Tianjin Medical Artificial Cardiopulmonary Machine Product
Table 99. Tianjin Medical Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Artificial Cardiopulmonary Machine Distributors List
Table 103. Artificial Cardiopulmonary Machine Customers List
Table 104. Artificial Cardiopulmonary Machine Market Trends
Table 105. Artificial Cardiopulmonary Machine Market Drivers
Table 106. Artificial Cardiopulmonary Machine Market Challenges
Table 107. Artificial Cardiopulmonary Machine Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Artificial Cardiopulmonary Machine
Figure 2. Global Artificial Cardiopulmonary Machine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Artificial Cardiopulmonary Machine Market Share by Type in 2022 & 2029
Figure 4. Single Roller Pump HLM Product Picture
Figure 5. Double Roller Pump HLM Product Picture
Figure 6. Global Artificial Cardiopulmonary Machine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Artificial Cardiopulmonary Machine Market Share by Application in 2022 & 2029
Figure 8. Cardiac Surgery
Figure 9. Lung Transplant Operation
Figure 10. Acute Respiratory Failure Treatment
Figure 11. Others
Figure 12. Global Artificial Cardiopulmonary Machine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Artificial Cardiopulmonary Machine Market Size (2018-2029) & (US$ Million)
Figure 14. Global Artificial Cardiopulmonary Machine Sales (2018-2029) & (K Units)
Figure 15. Global Artificial Cardiopulmonary Machine Average Price (US$/Unit) & (2018-2029)
Figure 16. Artificial Cardiopulmonary Machine Report Years Considered
Figure 17. Artificial Cardiopulmonary Machine Sales Share by Manufacturers in 2022
Figure 18. Global Artificial Cardiopulmonary Machine Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Artificial Cardiopulmonary Machine Players: Market Share by Revenue in 2022
Figure 20. Artificial Cardiopulmonary Machine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Artificial Cardiopulmonary Machine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Artificial Cardiopulmonary Machine Sales Market Share by Country (2018-2029)
Figure 23. North America Artificial Cardiopulmonary Machine Revenue Market Share by Country (2018-2029)
Figure 24. United States Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Artificial Cardiopulmonary Machine Sales Market Share by Country (2018-2029)
Figure 27. Europe Artificial Cardiopulmonary Machine Revenue Market Share by Country (2018-2029)
Figure 28. Germany Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Artificial Cardiopulmonary Machine Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Artificial Cardiopulmonary Machine Revenue Market Share by Region (2018-2029)
Figure 35. China Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Artificial Cardiopulmonary Machine Sales Market Share by Country (2018-2029)
Figure 45. Latin America Artificial Cardiopulmonary Machine Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Artificial Cardiopulmonary Machine Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Artificial Cardiopulmonary Machine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Artificial Cardiopulmonary Machine by Type (2018-2029)
Figure 55. Global Revenue Market Share of Artificial Cardiopulmonary Machine by Type (2018-2029)
Figure 56. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Artificial Cardiopulmonary Machine by Application (2018-2029)
Figure 58. Global Revenue Market Share of Artificial Cardiopulmonary Machine by Application (2018-2029)
Figure 59. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Application (2018-2029)
Figure 60. Artificial Cardiopulmonary Machine Value Chain
Figure 61. Artificial Cardiopulmonary Machine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs